Nurix Therapeutics NRIX - Options Chain | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Nurix Therapeutics Inc (NRIX)
Nurix Therapeutics Inc (NRIX) Options

Nurix Therapeutics Inc (NRIX)

13.59

0.40

(3.03%)

Closed 17 March 7:00AM

Delayed by 15 minutes

13.59

0.00

(0.00%)

After Hours: 10:59AM

Delayed by 15 minutes

NRIX Options Flow

Calls

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	10.20	12.20	0.00	11.20	0.00	0.00 %	0	0	-
5.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
7.50	5.20	7.10	0.00	6.15	0.00	0.00 %	0	0	-
10.00	2.70	4.50	0.00	3.60	0.00	0.00 %	0	0	-
12.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
15.00	0.15	0.80	0.05	0.475	0.00	0.00 %	1	0	15/3/2025
17.50	0.70	0.20	0.70	0.45	0.00	0.00 %	0	46	-
20.00	0.00	0.50	0.00	0.00	0.00	0.00 %	0	0	-
22.50	0.10	0.70	0.10	0.40	0.00	0.00 %	0	790	-
25.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
30.00	0.00	3.50	0.00	0.00	0.00	0.00 %	0	0	-

Empower your portfolio: Real-time discussions and actionable trading ideas.

Puts

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
5.00	0.00	4.40	0.00	0.00	0.00	0.00 %	0	0	-
7.50	0.00	0.05	0.00	0.00	0.00	0.00 %	0	0	-
10.00	0.00	4.40	0.00	0.00	0.00	0.00 %	0	0	-
12.50	0.00	0.95	0.00	0.00	0.00	0.00 %	0	0	-
15.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
17.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
20.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
22.50	8.30	10.00	0.00	9.15	0.00	0.00 %	0	0	-
25.00	10.80	13.20	0.00	12.00	0.00	0.00 %	0	0	-
30.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
RDUSRadius Recycling Inc	US$ 27.902 (104.26%)	8.53M
BONBon Natural Life Ltd	US$ 1.40 (90.29%)	84M
SUNESUNation Energy Inc	US$ 0.5213 (62.96%)	513.96M
WHLRLWheeler Real Estate Investment Trust Inc	US$ 255.00 (39.80%)	222
AAOIApplied Optoelectronics Inc	US$ 22.105 (39.29%)	17.01M
GLSTUGlobal Star Acquisition Inc	US$ 2.00 (-69.23%)	421
CURRCurrenc Group Inc	US$ 2.03 (-41.33%)	1.42M
ADTXAditxt Inc	US$ 0.0201 (-39.82%)	240.2M
HEPAHepion Pharmaceuticals Inc	US$ 0.0228 (-39.68%)	161.52M
WKSPWorksport Ltd	US$ 0.36205 (-35.45%)	4.96M
SUNESUNation Energy Inc	US$ 0.5213 (62.96%)	513.96M
NVDANVIDIA Corporation	US$ 121.67 (5.27%)	277.56M
ADTXAditxt Inc	US$ 0.0201 (-39.82%)	240.2M
HEPAHepion Pharmaceuticals Inc	US$ 0.0228 (-39.68%)	161.52M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 9.225 (7.64%)	160.21M

Monksdream

Monksdream 5 months ago

NRIX 10Q due Oct 17

Monksdream

Monksdream 5 months ago

NRIX 10 Q due 10 October

Monksdream

Monksdream 6 months ago

NRIX creeping higher

Monksdream

Monksdream 8 months ago

NRIX 10 Q expected JULY11

Monksdream

Monksdream 9 months ago

NRIX new 52 week high

Monksdream

Monksdream 9 months ago

NRIX more new highs up ahead

Monksdream

Monksdream 11 months ago

Monksdream

Monksdream 11 months ago

Monksdream

Monksdream 1 year ago

NRIX new 52 week high

TheFinalCD

TheFinalCD 3 years ago

https://ih.advfn.com/stock-market/NASDAQ/nurix-therapeutics-NRIX/stock-news/88898489/cathie-wood-doubles-down-on-these-2-strong-buy

infamous

infamous 4 years ago

what the F is wrong with this fkn stock? does it ever go up???

Phosphene

Phosphene 4 years ago

CEO: Dr. Arthur T. Sands

https://www.nurixtx.com/arthur-t-sands-m-d-ph-d/

Phosphene

Phosphene 4 years ago

Strategic partnerships with Sanofi and Gilead Sciences Inc.

https://www.nurixtx.com/research-development/strategic-partnerships/

Wellington and Baker Brothers are among Institutional Ownership and Shareholders:

https://fintel.io/so/us/nrix?__cf_chl_jschl_tk__=c9a7439112376e9f70de91c1316dfcc7e26d3519-1607403189-0-AT-0XpHMlNGWmcEzimwDKelDxLnOK6gsd8IihalGD8DcDe76KQlrWnh2Q1G3OLjfsidXSQyjVOkcCg3lXIXgKu6RIlw8DMusjRJpgnTzQP2qkahd1WSCP-5At2BI9Udfzc2vqpmlZOV3prAMIdFIh1_urJuBNq7hGlM4oSEJKFEFs8WDerUagukeDe9yBmvVg0Ne17vR8ByRaN-BlyHHxPWeTerJ_ZHoD1jnsxFYInhjhkK-XNkhe3BJ0Wzq3782kDVndNMNsb1glMkmm_NlSnc8Xbwve1nF3nGShcpgUxA-nefEgd9L74SzGXF1WftTIX4HYgwtb1BRzq82RClNfm9dr9Xb-hKp3xKKiYL4k9KfqV9OAePxDJoYgKqLUziXoA

Phosphene

Phosphene 4 years ago

Data support a planned clinical trial of NX-2127 in B-cell malignancies

http://www.globenewswire.com/news-release/2020/12/07/2140737/0/en/Nurix-Therapeutics-Presents-Preclinical-Data-at-62nd-American-Society-of-Hematology-ASH-Annual-Meeting-and-Exposition.html

Nurix Therapeutics

Bmo Growth Etf Portfolio...

First Trust FactorFX UCI...

Ci International Value C...

DAXsubsector Software Kurs

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions